Evolving importance of kidney disease: from subspecialty to global health burden

KU Eckardt, J Coresh, O Devuyst, RJ Johnson… - The Lancet, 2013 - thelancet.com
In the past decade, kidney disease diagnosed with objective measures of kidney damage
and function has been recognised as a major public health burden. The population …

Recent advances in nanotechnology-based drug delivery systems for the kidney

F Oroojalian, F Charbgoo, M Hashemi, A Amani… - Journal of controlled …, 2020 - Elsevier
The application of nanotechnology in medicine has the potential to make a great impact on
human health, ranging from prevention to diagnosis and treatment of disease. The kidneys …

The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice

W Zhou, W Wu, Z Si, H Liu, H Wang, H Jiang… - Nature …, 2022 - nature.com
Renal fibrosis is an inevitable outcome of various manifestations of progressive chronic
kidney diseases (CKD). The need for efficacious treatment regimen against renal fibrosis …

[HTML][HTML] Endothelin and endothelin antagonists in chronic kidney disease

DE Kohan, M Barton - Kidney international, 2014 - Elsevier
The incidence and prevalence of chronic kidney disease (CKD), with diabetes and
hypertension accounting for the majority of cases, is on the rise, with up to 160 million …

Microneedle coupled epidermal sensor for multiplexed electrochemical detection of kidney disease biomarkers

L Zheng, D Zhu, Y Xiao, X Zheng, P Chen - Biosensors and Bioelectronics, 2023 - Elsevier
Early diagnosis of chronic kidney disease (CKD) and constant monitoring to guide optimal
intervention is critical to prevent renal failure and other critical diseases. However, the …

Mechanisms and treatment of CKD

P Ruggenenti, P Cravedi… - Journal of the American …, 2012 - journals.lww.com
As CKD continues to increase worldwide, along with the demand for related life-saving
therapies, the financial burden of CKD will place an increasing drain on health care systems …

Health benefits of resveratrol in kidney disease: evidence from in vitro and in vivo studies

DJ Den Hartogh, E Tsiani - Nutrients, 2019 - mdpi.com
Different diseases and disorders that affect the kidneys include, but are not limited to,
glomerulonephritis, diabetic nephropathy, polycystic kidney disease, kidney stones, renal …

Folic acid and homocysteine in chronic kidney disease and cardiovascular disease progression: which comes first

G Cianciolo, A De Pascalis, L Di Lullo, C Ronco… - Cardiorenal …, 2017 - karger.com
Abstract Background: Hyperhomocysteinemia (Hhcy) occurs in about 85% of chronic kidney
disease (CKD) patients because of impaired renal metabolism and reduced renal excretion …

[HTML][HTML] Comprehensive review of current management guidelines of chronic kidney disease

C Elendu, RC Elendu, JM Enyong, JO Ibhiedu… - Medicine, 2023 - journals.lww.com
Chronic kidney disease (CKD) is a prevalent and progressive condition affecting millions
worldwide. It is a long-term condition characterized by gradual loss of kidney function over …

Nurse practitioner care improves renal outcome in patients with CKD

MJ Peeters, AD van Zuilen… - Journal of the …, 2014 - journals.lww.com
Abstract Treatment goals for patients with CKD are often unrealized for many reasons, but
support by nurse practitioners may improve risk factor levels in these patients. Here, we …